FDA urges adherence to specified intervals of mRNA COVID-19 vaccines
The Food and Drug Administration reminded the public of the importance of receiving COVID-19 vaccines in accordance to their agency authorizations, a process that FDA said will safely provide the “remarkable” levels of protection observed during large, randomized clinical trials.
Both approved vaccines, of the mRNA type, are approved for administration via two separate doses, given at either three- or four-week intervals.
“The available data continue to support the use of two specified doses of each authorized vaccine at specified intervals,” FDA said.
2020 has been hard for many, but it has been especially challenging for doctors, nurses and health care workers.
AHA released a public service announcement thanking healthcare professionals working in America’s hospitals and and health systems for their dedication and compassion caring for communities throughout a relentless 2020.
We invite you to thank the women and men at your local hospital or health system for all they do to keep us healthy and safe.
